Physician

Gerardo Midence, MD

According to 2025 Medicare claims, Gerardo Midence, MD (NPI: 1215981832) practices hematology/oncology in the Lewiston, ID-WA market, with the plurality of this provider's patient population coming from Nez Perce, ID. This provider's primary affiliated billing organization is ST JOSEPH HOSPITAL LLC (NPI: 1205368404; TIN: 36-4851166) and primary practice location at 83501-2431. Midence is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621), Caravan Collaborative Pathways (ACO ID: A4604), AdvantagePoint Health Alliance - Northwest, LLC (ACO ID: A5025), Caravan Health ACO 50 LLC (ACO ID: A5160), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Midence's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 300 traditional Medicare patients, billed 712 HCPCS/CPT codes, and received $61,635 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,164 prescription claims across 201 beneficiaries totaling $3,054,899 in drug costs, led by Brukinsa (Zanubrutinib). DME data shows 12 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,034,105 to $3,054,899. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $5,045 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	402	1,258	$75,682
2016	429	1,254	$75,417
2017	448	1,218	$75,627
2018	422	1,177	$69,037
2019	404	1,233	$67,699
2020	371	1,099	$59,903
2021	314	872	$67,754
2022	369	1,091	$85,931
2023	339	887	$75,461
2024	300	712	$61,635

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	200	1,812	$1,034,105
2016	237	1,840	$1,194,715
2017	213	1,439	$1,344,751
2018	224	1,526	$1,842,379
2019	221	1,692	$2,441,021
2020	232	1,638	$3,158,661
2021	244	1,866	$3,269,940
2022	217	1,553	$3,084,235
2023	199	1,207	$2,642,274
2024	201	1,164	$3,054,899

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	51	$49,711
2016	11	140	$36,620
2017	N/R	143	$16,316
2018	N/R	190	$22,476
2019	N/R	122	$9,365
2020	N/R	95	$4,340
2021	12	129	$7,873
2022	N/R	31	$1,330
2023	N/R	62	$1,085
2024	N/R	12	$226

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	81	81	$129
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	120	235	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	205	358	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	25	26	$43

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	45	1,350	$595,844
Imbruvica	Ibrutinib	39	1,098	$532,146
Ibrance	Palbociclib	19	532	$342,765
Pomalyst	Pomalidomide	12	336	$293,570
Xalkori	Crizotinib	12	360	$251,609

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$226

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Gerardo Midence, MD?

Tedicare shows public-source Medicare data for Gerardo Midence, MD (NPI 1215981832), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gerardo Midence, MD have ACO affiliation data?

Gerardo Midence, MD is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621), Caravan Collaborative Pathways (MSSP, ACO ID A4604), AdvantagePoint Health Alliance - Northwest, LLC (MSSP, ACO ID A5025), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Gerardo Midence, MD?

Gerardo Midence, MD is linked to ST JOSEPH HOSPITAL LLC (billing NPI 1205368404) in the available physician profile data.

Does Gerardo Midence, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.